» Articles » PMID: 20193005

Secondary and Ectopic Lymphoid Tissue Responses in Rheumatoid Arthritis: from Inflammation to Autoimmunity and Tissue Damage/remodeling

Overview
Journal Immunol Rev
Date 2010 Mar 3
PMID 20193005
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Rheumatoid arthritis is a chronic systemic inflammatory disease primarily affecting the synovium of diarthrodial joints. Despite the currently unknown etiology, overwhelming evidence indicates that both innate and adaptive immunity play a central role in disease pathogenesis. In this review, we consider recent evidence examining the mechanisms of lymphoid tissue reactivity in rheumatoid arthritis with a focus on the dynamics controlling secondary and ectopic lymphoid tissue response. We then examine the cellular and molecular mechanisms regulating the biopathology of these processes with specific emphasis on cell trafficking, contribution to autoimmunity, and joint damage-repair. We finally provide a brief overview of the most recent studies addressing the clinical relevance of synovial lymphoid tissue analysis as a diagnostic and prognostic tool as well as its response to current biological therapies.

Citing Articles

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.

Lopez de Rodas M, Villalba-Esparza M, Sanmamed M, Chen L, Rimm D, Schalper K Nat Rev Clin Oncol. 2025; 22(3):163-181.

PMID: 39820025 DOI: 10.1038/s41571-024-00984-x.


The clinical and pathological significance of tertiary lymphoid structure in extramammary Paget's disease.

Xi N, Xu X, Xu M, Wu N, Wu Y, Chen J Front Immunol. 2024; 15:1435629.

PMID: 39620222 PMC: 11604613. DOI: 10.3389/fimmu.2024.1435629.


Tertiary lymphoid structures in ovarian cancer.

Sun G, Liu Y Front Immunol. 2024; 15:1465516.

PMID: 39569184 PMC: 11576424. DOI: 10.3389/fimmu.2024.1465516.


Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.

Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z Signal Transduct Target Ther. 2024; 9(1):225.

PMID: 39198425 PMC: 11358547. DOI: 10.1038/s41392-024-01947-5.


Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity.

Shen S, Cui Y, Li M, Yu K, Zhu Q, Zhang X Neuro Oncol. 2024; 27(1):140-154.

PMID: 39188155 PMC: 11726345. DOI: 10.1093/neuonc/noae167.